company background image
OIL logo

Optiscan Imaging CHIA:OIL Stock Report

Last Price

AU$0.16

Market Cap

AU$142.0m

7D

-3.0%

1Y

97.5%

Updated

21 Dec, 2024

Data

Company Financials

Optiscan Imaging Limited

CHIA:OIL Stock Report

Market Cap: AU$142.0m

OIL Stock Overview

Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. More details

OIL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Earnings have declined by 25.8% per year over past 5 years

Does not have meaningful revenue (A$3M)

Does not have a meaningful market cap (A$142M)


My Notes

Capture your thoughts, links and company narrative

Optiscan Imaging Limited Competitors

Cyclopharm

ASX:CYC

AU$167.8m

ImpediMed

ASX:IPD

AU$103.2m

SomnoMed

ASX:SOM

AU$91.8m

Austco Healthcare

ASX:AHC

AU$98.3m

Price History & Performance

Summary of share price highs, lows and changes for Optiscan Imaging
Historical stock prices
Current Share PriceAU$0.16
52 Week HighAU$0.26
52 Week LowAU$0.072
Beta1.34
1 Month Change0%
3 Month Change6.67%
1 Year Change97.53%
3 Year Change-13.51%
5 Year Change321.05%
Change since IPO220.00%

Recent News & Updates

Recent updates

Shareholder Returns

OILAU Medical EquipmentAU Market
7D-3.0%-1.1%-2.7%
1Y97.5%0.4%6.5%

Return vs Industry: OIL exceeded the Australian Medical Equipment industry which returned 0.4% over the past year.

Return vs Market: OIL exceeded the Australian Market which returned 6.5% over the past year.

Price Volatility

Is OIL's price volatile compared to industry and market?
OIL volatility
OIL Average Weekly Movement11.1%
Medical Equipment Industry Average Movement8.8%
Market Average Movement8.0%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market3.1%

Stable Share Price: OIL has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: OIL's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994n/aCamile Farahwww.optiscan.com

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery.

Optiscan Imaging Limited Fundamentals Summary

How do Optiscan Imaging's earnings and revenue compare to its market cap?
OIL fundamental statistics
Market capAU$142.01m
Earnings (TTM)-AU$6.06m
Revenue (TTM)AU$2.99m

47.6x

P/S Ratio

-23.4x

P/E Ratio

Is OIL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OIL income statement (TTM)
RevenueAU$2.99m
Cost of RevenueAU$526.20k
Gross ProfitAU$2.46m
Other ExpensesAU$8.52m
Earnings-AU$6.06m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0073
Gross Margin82.38%
Net Profit Margin-202.96%
Debt/Equity Ratio0.3%

How did OIL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 21:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Optiscan Imaging Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution